Half an inch determined the outcome of a $260 million Department of Veterans Affairs (VA) procurement in Joerns Healthcare, LLC v. United States, a bid protest in which the US Court of Federal Claims (COFC) enforced strict compliance with solicitation specifications. The court rejected the contractor’s reliance on industry standards, holding that unambiguous solicitation terms control evaluation outcomes when agencies verify compliance through stated measurement methods. For contractors competing in FAR Part 12 commercial item acquisitions and FAR Part 15 procurements, the decision reinforces that even minimal deviations from express requirements can render a proposal unacceptable.
Continue Reading Half an Inch from a Quarter-Billion: COFC Tells Contractors to Read the Spec, Not the Industry
Cost-Plus Out. Fixed-Price In.
A 2026 federal executive order reshapes federal procurement policy by directing agencies to use fixed-price contracts as the default under FAR Part 16, while requiring written justification and higher-level approval for cost-reimbursement, time-and-material, and labor-hour contracts. The order also establishes agency approval thresholds, carve-outs for R&D and contingency work, and a phased implementation schedule through OMB guidance and FAR Council rulemaking. For government contractors, the change affects how agencies structure acquisitions, allocate risk, and modify existing and future contracts, with significant implications for federal procurement strategy and compliance in 2026.
Continue Reading Cost-Plus Out. Fixed-Price In.Everything Everywhere All at Once: The Contractor DEI Clause Hits HR, Supply Chains, Invoices, and Subcontracts
Federal contractors looking for the “DEI issue” in FAR 52.222-90 may be looking in the wrong place. Yes, the clause is about what Executive Order 14398 calls “racially discriminatory DEI activities.” But that’s only the starting point. The new clause also reaches subcontract flowdowns, records access, reporting obligations, bilateral modifications, suspension and debarment, and False Claims Act (FCA) risk. This isn’t just an HR issue, and it isn’t just a DEI issue. It is a contract-administration issue, a supply-chain issue, and an invoice issue all at once.
Continue Reading Everything Everywhere All at Once: The Contractor DEI Clause Hits HR, Supply Chains, Invoices, and SubcontractsDOJ Stands Up a New Fraud-Fighting Division: What Government Contractors Need to Know About the National Fraud Enforcement Division
On April 7, 2026, Acting Attorney General Todd Blanche issued a memorandum establishing the National Fraud Enforcement Division (“NFED”) within the U.S. Department of Justice (“DOJ”). Announced in a corresponding DOJ press release, the NFED is the Department’s first unified litigating division dedicated exclusively to investigating and prosecuting fraud against taxpayer dollars. For the government contractor community, the creation of the NFED represents a meaningful escalation in federal fraud enforcement.
Continue Reading DOJ Stands Up a New Fraud-Fighting Division: What Government Contractors Need to Know About the National Fraud Enforcement DivisionWhen “Reasonable” Means More Than a Weekend: GAO Sustains Protest Over Compressed Response Times
A contracting officer issues a solicitation amendment on a Friday afternoon, reverses course by Friday evening and demands a revised quotation by noon on Saturday, then changes the requirements again on both Sunday and Monday with a response window of as little as one hour. The agency’s own suggested solution? Ordering a refrigerator manufactured in Turkey, not available for purchase in the United States. If this sounds like a procurement that went off the rails, the GAO agrees.
Continue Reading When “Reasonable” Means More Than a Weekend: GAO Sustains Protest Over Compressed Response TimesBeyond the Headlines: The Real Contractor Risks in the New DEI Executive Order
The biggest danger may be misreading the order—and creating new exposure in the process.
On March 26, 2026, President Trump issued an executive order (EO) titled “Addressing DEI Discrimination by Federal Contractors.” Read at the headline level, the order can sound like another broad anti-diversity, equity, and inclusion (DEI) pronouncement. Read as a procurement directive, however, it is something more concrete and more consequential: a command to federal agencies to begin inserting a mandatory clause into covered contracts and contract-like instruments, including subcontracts and lower-tier subcontracts, within 30 days. That shift, from messaging to mechanics, is the real story.
Continue Reading Beyond the Headlines: The Real Contractor Risks in the New DEI Executive OrderSBA Expands Administrative False Claims Act Enforcement: What Federal Contractors Need to Know
The Administrative False Claims Act of 2023 (AFCA), Pub. L. 118-159, § 5203, enacted December 23, 2024, substantially amended the Program Fraud Civil Remedies Act (PFCRA). On March 19, 2026, the Small Business Administration (SBA) published a direct final rule conforming its regulations to those statutory changes. 91 Fed. Reg. 13217 (Mar. 19, 2026). Absent significant adverse comment, the rule becomes effective May 4, 2026. Together, the AFCA amendments and the conforming rule materially expand SBA’s enforcement reach, raise the jurisdictional threshold for administrative proceedings, extend the statute of limitations, and introduce reverse false claims liability. Contractors doing business with SBA—or whose programs touch SBA loans, grants, or set-aside contracts—should act now.
Continue Reading SBA Expands Administrative False Claims Act Enforcement: What Federal Contractors Need to KnowSpring Cleaning Your Proposals: GAO’s Latest Reminder That Compliance Is Critical
As we move into spring—a season for tightening processes, clearing the backlog, and getting every detail right—a recent Government Accountability Office (GAO) bid protest decision delivers a timely reminder: in government contracting, a single compliance miss can be outcome determinative.
Last month, in Morrish-Wallace Construction, Inc. d/b/a Ryba Marine Construction Co., the GAO sustained a protest where the agency awarded a contract to a bidder that failed to acknowledge a material solicitation amendment. The decision is an instructive case study in why amendment acknowledgment is not just a box to check—it also is a binding legal act.
Continue Reading Spring Cleaning Your Proposals: GAO’s Latest Reminder That Compliance Is CriticalDon’t Panic! How Federal Contractors Should Navigate the Anthropic Designation
In every crisis, half the room runs in circles while the other half picks up a clipboard and starts taking stock. The Anthropic-Pentagon dispute is that crisis, and defense contractors are deciding which half they want to be in.
The short version: The government designated a FedRAMP-authorized, facility-cleared American AI company a national security supply chain threat, via social media, after the company refused to remove safety restrictions on autonomous weapons and mass surveillance. Anthropic sued days later, with the Pentagon’s own officials on the record stating the designation was “ideologically driven” with “no evidence of supply chain risk.”
Continue Reading Don’t Panic! How Federal Contractors Should Navigate the Anthropic DesignationThe BIOSECURE Act and the Expanding Life Sciences Supply Chain: Practical Considerations for Research-Driven Industries
In a previous posting, we flagged how the BIOSECURE Act (enacted as Section 851 of the Fiscal Year 2026 National Defense Authorization Act) reflects a growing focus on biotechnology supply chains within federal procurement. The statute is designed around a simple premise: Biotechnology risks rarely appear at the level of the final product. Instead, the risks tend to emerge through tools, platforms, and service providers embedded in the performance of federally funded work.
Nowhere is that observation more apparent than in industries adjacent to biotechnology that rely heavily on biological data, specialized testing infrastructure, or outsourced research capabilities. Examples include pharmaceutical and biologics developers, medical device and diagnostics manufacturers, contract research organizations (CROs) and specialized laboratory providers, healthcare and academic research institutions participating in federally funded programs, and technology companies supporting biological data analytics or laboratory automation. For these sectors, biotechnology may not define the business model, but it plays a quiet yet significant operational role in how products are discovered, validated, and manufactured. The BIOSECURE Act brings those operational dependencies into sharper focus.
Continue Reading The BIOSECURE Act and the Expanding Life Sciences Supply Chain: Practical Considerations for Research-Driven Industries